Yoshida O - Search Results

1

Detection of multidrug resistance (MDR1) gene RNA expression in human tumors by a sensitive ribonuclease protection assay.

Ueda K, Yamano Y, Kioka N, Kakehi Y, Yoshida O, Gottesman MM, Pastan I, Komano T. Ueda K, et al. Among authors: yoshida o. Jpn J Cancer Res. 1989 Nov;80(11):1127-32. doi: 10.1111/j.1349-7006.1989.tb02269.x. Jpn J Cancer Res. 1989. PMID: 2481665 Free PMC article.

2

MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants.

Kanamaru H, Kakehi Y, Yoshida O, Nakanishi S, Pastan I, Gottesman MM. Kanamaru H, et al. Among authors: yoshida o. J Natl Cancer Inst. 1989 Jun 7;81(11):844-9. doi: 10.1093/jnci/81.11.844. J Natl Cancer Inst. 1989. PMID: 2724349

3

Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.

Kakehi Y, Kanamaru H, Yoshida O, Ohkubo H, Nakanishi S, Gottesman MM, Pastan I. Kakehi Y, et al. Among authors: yoshida o. J Urol. 1988 Apr;139(4):862-5. doi: 10.1016/s0022-5347(17)42663-2. J Urol. 1988. PMID: 3352061

4

Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line.

Kim WJ, Kakehi Y, Hirai M, Arao S, Hiai H, Fukumoto M, Yoshida O. Kim WJ, et al. Among authors: yoshida o. Jpn J Cancer Res. 1995 Oct;86(10):969-77. doi: 10.1111/j.1349-7006.1995.tb03009.x. Jpn J Cancer Res. 1995. PMID: 7493917 Free PMC article.

5

Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.

Kakehi Y, Wu WJ, Kim WJ, Arao S, Fukumoto M, Yoshida O. Kakehi Y, et al. Among authors: yoshida o. Int J Urol. 1995 Nov;2(5):309-15. Int J Urol. 1995. PMID: 8749949 Free article.

6

Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.

Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshida O. Ogawa O, et al. Among authors: yoshida o. Cancer Res. 1991 Feb 1;51(3):949-53. Cancer Res. 1991. PMID: 1671000

7

Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.

Kakehi Y, Yoshida O. Kakehi Y, et al. Among authors: yoshida o. Int J Cancer. 1989 Mar 15;43(3):391-4. doi: 10.1002/ijc.2910430307. Int J Cancer. 1989. PMID: 2564378

8

Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.

Wu WJ, Kakehi Y, Habuchi T, Kinoshita H, Ogawa O, Terachi T, Huang CH, Chiang CP, Yoshida O. Wu WJ, et al. Among authors: yoshida o. Jpn J Cancer Res. 1995 Aug;86(8):730-6. doi: 10.1111/j.1349-7006.1995.tb02461.x. Jpn J Cancer Res. 1995. PMID: 7559095 Free PMC article.

9

Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.

Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida O, Ueda K, Komano T, et al. Hirai M, et al. Among authors: yoshida o. J Pharmacol Exp Ther. 1995 Oct;275(1):73-8. J Pharmacol Exp Ther. 1995. PMID: 7562598

10

Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.

Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O. Oka H, et al. Among authors: yoshida o. Cancer Res. 1995 Sep 15;55(18):4182-7. Cancer Res. 1995. PMID: 7664295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

960 results

Search Page

Filters